位置:首页 > 蛋白库 > GYRA_SHIFL
GYRA_SHIFL
ID   GYRA_SHIFL              Reviewed;         875 AA.
AC   P0AES5; P09097;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   03-AUG-2022, entry version 120.
DE   RecName: Full=DNA gyrase subunit A {ECO:0000255|HAMAP-Rule:MF_01897};
DE            EC=5.6.2.2 {ECO:0000255|HAMAP-Rule:MF_01897};
GN   Name=gyrA {ECO:0000255|HAMAP-Rule:MF_01897};
GN   OrderedLocusNames=SF2311, S2444;
OS   Shigella flexneri.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=623;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=301 / Serotype 2a;
RX   PubMed=12384590; DOI=10.1093/nar/gkf566;
RA   Jin Q., Yuan Z., Xu J., Wang Y., Shen Y., Lu W., Wang J., Liu H., Yang J.,
RA   Yang F., Zhang X., Zhang J., Yang G., Wu H., Qu D., Dong J., Sun L.,
RA   Xue Y., Zhao A., Gao Y., Zhu J., Kan B., Ding K., Chen S., Cheng H.,
RA   Yao Z., He B., Chen R., Ma D., Qiang B., Wen Y., Hou Y., Yu J.;
RT   "Genome sequence of Shigella flexneri 2a: insights into pathogenicity
RT   through comparison with genomes of Escherichia coli K12 and O157.";
RL   Nucleic Acids Res. 30:4432-4441(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700930 / 2457T / Serotype 2a;
RX   PubMed=12704152; DOI=10.1128/iai.71.5.2775-2786.2003;
RA   Wei J., Goldberg M.B., Burland V., Venkatesan M.M., Deng W., Fournier G.,
RA   Mayhew G.F., Plunkett G. III, Rose D.J., Darling A., Mau B., Perna N.T.,
RA   Payne S.M., Runyen-Janecky L.J., Zhou S., Schwartz D.C., Blattner F.R.;
RT   "Complete genome sequence and comparative genomics of Shigella flexneri
RT   serotype 2a strain 2457T.";
RL   Infect. Immun. 71:2775-2786(2003).
CC   -!- FUNCTION: A type II topoisomerase that negatively supercoils closed
CC       circular double-stranded (ds) DNA in an ATP-dependent manner to
CC       modulate DNA topology and maintain chromosomes in an underwound state.
CC       Negative supercoiling favors strand separation, and DNA replication,
CC       transcription, recombination and repair, all of which involve strand
CC       separation. Also able to catalyze the interconversion of other
CC       topological isomers of dsDNA rings, including catenanes and knotted
CC       rings. Type II topoisomerases break and join 2 DNA strands
CC       simultaneously in an ATP-dependent manner. {ECO:0000255|HAMAP-
CC       Rule:MF_01897}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-dependent breakage, passage and rejoining of double-
CC         stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01897};
CC   -!- SUBUNIT: Heterotetramer, composed of two GyrA and two GyrB chains. In
CC       the heterotetramer, GyrA contains the active site tyrosine that forms a
CC       transient covalent intermediate with DNA, while GyrB binds cofactors
CC       and catalyzes ATP hydrolysis. {ECO:0000255|HAMAP-Rule:MF_01897}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01897}.
CC   -!- MISCELLANEOUS: Few gyrases are as efficient as E.coli at forming
CC       negative supercoils. Not all organisms have 2 type II topoisomerases;
CC       in organisms with a single type II topoisomerase this enzyme also has
CC       to decatenate newly replicated chromosomes. {ECO:0000255|HAMAP-
CC       Rule:MF_01897}.
CC   -!- SIMILARITY: Belongs to the type II topoisomerase GyrA/ParC subunit
CC       family. {ECO:0000255|HAMAP-Rule:MF_01897}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE005674; AAN43827.1; -; Genomic_DNA.
DR   EMBL; AE014073; AAP17645.1; -; Genomic_DNA.
DR   RefSeq; NP_708120.1; NC_004337.2.
DR   RefSeq; WP_001281242.1; NZ_WHSI01000112.1.
DR   PDB; 2Y3P; X-ray; 2.62 A; A/B=2-523.
DR   PDBsum; 2Y3P; -.
DR   AlphaFoldDB; P0AES5; -.
DR   SMR; P0AES5; -.
DR   STRING; 198214.SF2311; -.
DR   PRIDE; P0AES5; -.
DR   EnsemblBacteria; AAN43827; AAN43827; SF2311.
DR   EnsemblBacteria; AAP17645; AAP17645; S2444.
DR   GeneID; 1027274; -.
DR   GeneID; 66673880; -.
DR   KEGG; sfl:SF2311; -.
DR   KEGG; sfx:S2444; -.
DR   PATRIC; fig|198214.7.peg.2769; -.
DR   HOGENOM; CLU_002977_6_1_6; -.
DR   OMA; THHWLLF; -.
DR   OrthoDB; 217468at2; -.
DR   EvolutionaryTrace; P0AES5; -.
DR   Proteomes; UP000001006; Chromosome.
DR   Proteomes; UP000002673; Chromosome.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0034335; F:DNA negative supercoiling activity; IEA:UniProt.
DR   GO; GO:0006265; P:DNA topological change; IEA:UniProtKB-UniRule.
DR   GO; GO:0006261; P:DNA-templated DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   CDD; cd00187; TOP4c; 1.
DR   Gene3D; 1.10.268.10; -; 1.
DR   Gene3D; 2.120.10.90; -; 1.
DR   Gene3D; 3.90.199.10; -; 1.
DR   HAMAP; MF_01897; GyrA; 1.
DR   InterPro; IPR005743; GyrA.
DR   InterPro; IPR006691; GyrA/parC_rep.
DR   InterPro; IPR035516; Gyrase/topoIV_suA_C.
DR   InterPro; IPR013760; Topo_IIA-like_dom_sf.
DR   InterPro; IPR013758; Topo_IIA_A/C_ab.
DR   InterPro; IPR013757; Topo_IIA_A_a_sf.
DR   InterPro; IPR002205; Topo_IIA_dom_A.
DR   Pfam; PF03989; DNA_gyraseA_C; 6.
DR   Pfam; PF00521; DNA_topoisoIV; 1.
DR   SMART; SM00434; TOP4c; 1.
DR   SUPFAM; SSF101904; SSF101904; 1.
DR   SUPFAM; SSF56719; SSF56719; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; ATP-binding; Cytoplasm; DNA-binding;
KW   Isomerase; Nucleotide-binding; Reference proteome; Topoisomerase.
FT   CHAIN           1..875
FT                   /note="DNA gyrase subunit A"
FT                   /id="PRO_0000145249"
FT   REGION          841..875
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           560..566
FT                   /note="GyrA-box"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01897"
FT   COMPBIAS        845..875
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        122
FT                   /note="O-(5'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01897"
FT   HELIX           15..17
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           24..33
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            37..39
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           43..54
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           66..76
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           84..91
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            95..97
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          102..107
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            120..122
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          124..127
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           129..134
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            135..139
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          145..147
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          151..158
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           165..169
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            174..177
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           187..199
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           205..211
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           227..235
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          236..243
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          245..250
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            252..254
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          257..263
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           270..282
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          288..294
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           313..321
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          327..333
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          335..338
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          341..344
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           347..388
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           390..399
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           403..412
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   TURN            418..420
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           421..424
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          441..449
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           452..460
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           463..466
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           469..492
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   HELIX           495..513
FT                   /evidence="ECO:0007829|PDB:2Y3P"
FT   STRAND          519..521
FT                   /evidence="ECO:0007829|PDB:2Y3P"
SQ   SEQUENCE   875 AA;  96964 MW;  3FD5BD52A5969069 CRC64;
     MSDLAREITP VNIEEELKSS YLDYAMSVIV GRALPDVRDG LKPVHRRVLY AMNVLGNDWN
     KAYKKSARVV GDVIGKYHPH GDSAVYDTIV RMAQPFSLRY MLVDGQGNFG SIDGDSAAAM
     RYTEIRLAKI AHELMADLEK ETVDFVDNYD GTEKIPDVMP TKIPNLLVNG SSGIAVGMAT
     NIPPHNLTEV INGCLAYIDD EDISIEGLME HIPGPDFPTA AIINGRRGIE EAYRTGRGKV
     YIRARAEVEV DAKTGRETII VHEIPYQVNK ARLIEKIAEL VKEKRVEGIS ALRDESDKDG
     MRIVIEVKRD AVGEVVLNNL YSQTQLQVSF GINMVALHHG QPKIMNLKDI IAAFVRHRRE
     VVTRRTIFEL RKARDRAHIL EALAVALANI DPIIELIRHA PTPAEAKTAL VANPWQLGNV
     AAMLERAGDD AARPEWLEPE FGVRDGLYYL TEQQAQAILD LRLQKLTGLE HEKLLDEYKE
     LLDQIAELLR ILGSADRLME VIREELELVR EQFGDKRRTE ITANSADINL EDLITQEDVV
     VTLSHQGYVK YQPLSEYEAQ RRGGKGKSAA RIKEEDFIDR LLVANTHDHI LCFSSRGRVY
     SMKVYQLPEA TRGARGRPIV NLLPLEQDER ITAILPVTEF EEGVKVFMAT ANGTVKKTVL
     TEFNRLRTAG KVAIKLVDGD ELIGVDLTSG EDEVMLFSAE GKVVRFKESS VRAMGCNTTG
     VRGIRLGEGD KVVSLIVPRG DGAILTATQN GYGKRTAVAE YPTKSRATKG VISIKVTERN
     GLVVGAVQVD DCDQIMMITD AGTLVRTRVS EISIVGRNTQ GVILIRTAED ENVVGLQRVA
     EPVDEEDLDT IDGSAAEGDD EIAPEVDVDD EPEEE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024